These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Stevens-Johnson syndrome, drug-induced hypersensitivity syndrome and toxic epidermal necrolysis caused by allopurinol in patients with a common HLA allele: what causes the diversity? Dainichi T, Uchi H, Moroi Y, Furue M. Dermatology; 2007 Aug; 215(1):86-8. PubMed ID: 17587850 [No Abstract] [Full Text] [Related]
6. Allopurinol is the most common cause of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and Israel. Halevy S, Ghislain PD, Mockenhaupt M, Fagot JP, Bouwes Bavinck JN, Sidoroff A, Naldi L, Dunant A, Viboud C, Roujeau JC, EuroSCAR Study Group. J Am Acad Dermatol; 2008 Jan; 58(1):25-32. PubMed ID: 17919772 [Abstract] [Full Text] [Related]
7. Strong association between HLA-B*5801 and allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in a Thai population. Tassaneeyakul W, Jantararoungtong T, Chen P, Lin PY, Tiamkao S, Khunarkornsiri U, Chucherd P, Konyoung P, Vannaprasaht S, Choonhakarn C, Pisuttimarn P, Sangviroon A, Tassaneeyakul W. Pharmacogenet Genomics; 2009 Sep; 19(9):704-9. PubMed ID: 19696695 [Abstract] [Full Text] [Related]
9. Human leukocyte antigen-related risk factors for toxic epidermal necrosis. Kemen C, Lemke J, Hoeger PH, Beckmann C, Hennenberger A, Detjen A, Magdorf K. Pediatr Infect Dis J; 2009 Jun; 28(6):552. PubMed ID: 19483528 [No Abstract] [Full Text] [Related]
10. [Fatal outcome in allopurinol hypersensitivity syndrome]. Kluger E. Ugeskr Laeger; 1998 Feb 16; 160(8):1179-80. PubMed ID: 9492630 [Abstract] [Full Text] [Related]
11. Risk estimates for drugs suspected of being associated with Stevens-Johnson syndrome and toxic epidermal necrolysis: a case-control study. Lin MS, Dai YS, Pwu RF, Chen YH, Chang NC. Intern Med J; 2005 Mar 16; 35(3):188-90. PubMed ID: 15737140 [Abstract] [Full Text] [Related]
12. Drug induced toxic epidermal necrolysis. Fong PH, Ratnagopal P, Wong KL. Singapore Med J; 1984 Jun 16; 25(3):184-6. PubMed ID: 6333073 [No Abstract] [Full Text] [Related]
13. Drug-induced Lyell and Stevens-Johnson syndromes. Prescrire Int; 2009 Feb 16; 18(99):20-2. PubMed ID: 19391288 [Abstract] [Full Text] [Related]
15. Toxic epidermal necrolysis. A case report. Bintliff SJ. Hawaii Med J; 1966 Jul 16; 25(6):468-9. PubMed ID: 5941109 [No Abstract] [Full Text] [Related]
16. [Lyell syndrome in a patient with Cushing disease]. Pfliegler G, Udvardy M, Thomázy V, Vezekényi K, Alföldi G. Orv Hetil; 1981 Nov 08; 122(45):2781-3. PubMed ID: 7322577 [No Abstract] [Full Text] [Related]
17. Severe cutaneous drug reactions: case reports. Herold M, Oltmanns G, Duck HJ, Maru M. Ethiop Med J; 1983 Oct 08; 21(4):227-32. PubMed ID: 6194993 [No Abstract] [Full Text] [Related]
18. [Artificial nutrition of patients with toxic epidermal necrolysis (Lyell syndrome)]. Kertai M, Dárdai E, Telkes M, Nébenführer L. Orv Hetil; 1997 Oct 12; 138(41):2609-11. PubMed ID: 9411331 [Abstract] [Full Text] [Related]
19. [Lyell's syndrome caused by allopurinol. Clinical case]. Balacco-Gabrieli C, Palmisano C, Lorusso V, Castellano L. Ophtalmologie; 1988 Oct 12; 2(2):123-6. PubMed ID: 3247146 [No Abstract] [Full Text] [Related]
20. Delayed reepithelialization and scarring deregulation following drug-induced toxic epidermal necrolysis. Paquet P, Jacob E, Quatresooz P, Jacquemin D, Piérard GE. Burns; 2007 Feb 12; 33(1):100-4. PubMed ID: 17079086 [Abstract] [Full Text] [Related] Page: [Next] [New Search]